0.4669  -0.019 (-3.85%)		08-28 16:00
Open: 0.4826 High: 0.4914 Volume: 374,923		Pre. Close: 0.4856 Low: 0.4602 Market Cap: 26(M)

Short term
Mid term
Targets	6-month :	0.65	1-year :	0.73
Resists	First :	0.56	Second :	0.62
Pivot price	0.51
Supports	First :	0.46	Second :	0.38
MAs	MA(5) :	0.48	MA(20) :	0.5
	MA(100) :	0.73	MA(250) :	1.26
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	6.6	D(3) :	10.1
RSI	RSI(14): 38.3
52-week	High :	4	Low :	0.46

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ BEAT ] has closed above bottom band by 23.5%. Bollinger Bands are 28% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.49 - 0.49	0.49 - 0.5
Low:	0.45 - 0.46	0.46 - 0.46
Close:	0.46 - 0.47	0.47 - 0.47

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.

Thu, 13 Aug 2026
HeartBeam, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:BEAT) 2026-08-13 - Seeking Alpha

Thu, 13 Aug 2026
HeartBeam (BEAT): Strome group details 6.8% ownership and July–August share sales - Stock Titan

Wed, 12 Aug 2026
HeartBeam Inc (BEAT) Q2 2026 Earnings Report Preview: What To Look For - Yahoo Finance

Fri, 24 Jul 2026
HeartBeam (NASDAQ: BEAT) CTO receives 105,740 shares in bonus grant - Stock Titan

Wed, 01 Jul 2026
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule - Business Wire

Sat, 27 Jun 2026
HeartBeam (BEAT) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Slower Ramp - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Specialties
Shares Out	56 (M)
Shares Float	47 (M)
Held by Insiders	19.5 (%)
Held by Institutions	14.3 (%)
Shares Short	1,840 (K)
Shares Short P.Month	1,790 (K)

EPS	-0.51
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-153.6 %
Return on Equity (ttm)	-328.5 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-0.37
Qtrly Earnings Growth	0 %
Operating Cash Flow	-13 (M)
Levered Free Cash Flow	-7 (M)

PE Ratio	-0.92
PEG Ratio	0
Price to Book value	46.68
Price to Sales	0
Price to Cash Flow	-2.03

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.